findmyKOL

Carol Shields, MD

Basic profile

Thomas Jefferson University

ORCIDNPI
RegionPhiladelphia, PA · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Carol Shields is an Ophthalmology physician affiliated with Thomas Jefferson University. OpenAlex indexes 1,901 publications with 62,350 citations (h-index 118); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Ophthalmology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,901publications

Distinct works indexed by OpenAlex, matched via ORCID.

62,350citations

Total citations across indexed works.

118h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

840 Walnut Street
Suite 1440
Philadelphia, PA 19107

Telephone

215-928-3105

Provider last certified this registry record 15 Feb 2022.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    45.3%
    Aminoglycoside Antibacterial45.3%
    Neomycin-Polymyxin-Dexameth100%
    Part D146 patients
  • Metabolism & gastrointestinal

    31.3%
    Anticholinergic16.8%
    Atropine Sulfate100%
    Part D58 patients
    Serotonin-3 Receptor Antagonist14.5%
    Ondansetron Odt73%Ondansetron Hcl27%
    Part D61 patients
  • Anti-infectives

    10.4%
    Macrolide10.4%
    Erythromycin100%
    Part D38 patients
Where care is delivered (Part B)6.1% facility · 93.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”